Canada’s 2003 renewed drug strategy — an evidence-based review — HIV/AIDS Policy & Law Review 11(2/3)
About three-quarters of the resources of Canada’s Drug Strategy are directed towards enforcement-related efforts, despite a lack of scientific evidence to support this approach and little, if any, evaluation of the impacts of this investment. In this feature article, the authors report on a study that examined expenditures and activities related to the Drug Strategy … Read more